Table 3. Incidence of primary and secondary endpoints.
| Good control (n=1733) | Poor control (n=1268) | P-value (log-rank) | |
|---|---|---|---|
| Primary endpoints | |||
| Composite cardiovascular events | 53 (8.2) | 56 (12.1) | 0.041 |
| Secondary endpoints | |||
| Hard composite cardiovascular events | 27 (4.1) | 33 (7.1) | 0.038 |
| Fatal and non-fatal stroke including TIA | 21 (3.2) | 27 (5.8) | 0.042 |
| Cardiac events | 24 (3.7) | 25 (5.3) | 0.196 |
| All-cause mortality | 33 (5.0) | 28 (5.9) | 0.474 |
| New-onset diabetes | 56 (8.7) | 34 (7.3) | 0.397 |
Abbreviation: TIA, transient ischemic attack.
Hard composite cardiovascular events were consist of cardiovascular death, non-fatal myocardial infarction and non-fatal stroke. Differences in the primary and secondary events between the good control group and the poor control group were analyzed using Tukey’s multiple comparison test. Data are shown as incidence number (per 1000 patients years).